Chronic brain inflammation can impact mood, cognition, and memory. Learn about some simple lifestyle changes that can help ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

Researchers at Tel Aviv University have made a fundamental discovery: the NMDA receptor (NMDAR)—long studied primarily for ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

Body composition emerges as a key factor in brain health, according to recent research. Targeted fat reduction and muscle ...

The AD risk factors/hits include high exposure to traffic-related air pollution (TRAP) and infections, as well as factors ...

Because November is Diabetes and Alzheimer’s awareness month, we are learning about the link between brain health and insulin ...

Taking Out OGA. The rationale behind small-molecule OGA inhibition is that these drugs will decrease tau hyperphosphorylation and aggregation into neurofibrillary tangles (right). [Courtesy of Eli ...

Researchers found that inhibiting the enzyme TYK2 may reduce the harmful accumulation of tau protein in Alzheimer’s disease, ...

Upon reexamination, the European Medicines Agency has made a U-turn on Eisai and Biogen’s Alzheimer’s disease drug Leqembi. | ...

An international collaboration led by RIKEN researchers has discovered how unusual spherical structures form in the brains of ...

Unexplained fluctuations in cholesterol levels have been linked to dementia and cognitive decline in a recent study.